Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in Pakistan

Completed

• Conditions: Postmenopausal Osteoporosis

• Registration Number: NCT02422069
• Lead Sponsor: Hoffmann-La Roche

Brief Summary

This observational study will provide an opportunity to document local patterns of susceptibility, patient profile, and usefulness of screening in postmenopausal patients coming to gynecology outpatient clinics in Pakistan. This will also capture the initial management of PMO in diagnosed patients. The information gathered will serve as a foundation for developing national guidelines on screening and management of PMO in Pakistan.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-04
• Primary Completion: 2011-12
• Study Completion: 2011-12
• Study First Submitted: 2015-04-16
• Study First Submitted QC: 2015-04-16
• Study First Posted: 2015-04-21
• Status Verified: 2016-11
• Last Update Submitted: 2016-11-01
• Last Update Posted: 2016-11-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 624

Inclusion Criteria

• Postmenopausal women
• Age 50 years or greater

Read More

Exclusion Criteria

• Previously diagnosed osteoporosis, or receiving treatment for osteoporosis

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage of patients diagnosed with PMO based upon dual-energy X-ray absorptiometry (DXA) results	Up to 12 months

Secondary Outcome Measures

Name	Time	Method
Use of various PMO treatment modalities	Up to 12 months